Nefecon in IgA Nephropathy, the Nefigard trial — NephJC
This week, we will discuss NEFIGARD, the trial of a targeted release steroid. It reduces proteinuria in IgA nephropathy – should it upstage humble prednisone?
This week, we will discuss NEFIGARD, the trial of a targeted release steroid. It reduces proteinuria in IgA nephropathy – should it upstage humble prednisone?
An abstract is unavailable. This article is available as a PDF only.
“Women in Nephrology Speakers Bureau Initiative” published on 07 May 2024 by American Society of Nephrology.
y populations. Methods: In this study, we applied Mendelian randomization and colocalization analyses to estimate the putative causal effects of 2615 proteins on IgA nephropathy…
CMS issues national coverage decisions that affect the nephrology practitioner’s ability to deliver quality renal patient care. The official coverage decisions, RPA’s comments and/or guidance…
Studies have shown that generally healthy individuals who consume diets rich in plant foods have a lower risk of incident chronic kidney disease (CKD) and…
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken,…
Become an ASN member by joining online or downloading the membership PDF.
“Predicting Cisplatin-Induced Kidney Injury: A Milestone in Onconephrology” published on 07 May 2024 by American Society of Nephrology.
for high-KDPI kidneys was associated with 15% higher adjusted rates of deceased donor transplantation. Background Despite known benefits of kidney transplantation, including transplantation from donors…
Nature Reviews Nephrology – In this Review, the authors provide an overview of the roles of miRNAs in the development of chronic kidney disease, acute…